Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modification of the Expression of ADARs and PDE8A Editing in Suicidal Behavior

NCT02855918 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02855918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02855918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modification of the Expression of ADARs and PDE8A Editing in Suicidal Behavior
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
September 23, 2016
Completion date
June 24, 2020
Enrollment
600 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression